Morphine actions in the rat forebrain: Role of protein kinase C

Brain Research Bulletin

Volumn 62, Issue 4, 2004, Pages 285-295

  Harlan, Richard E ^a   Kailas, Sudha R ^a   Tagoe, C E F ^a,b   Garcia, Meredith M ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GHANA   (Ghana)

Author keywords

c Fos; Glutamate receptors; Immediate early gene; Opiates

Indexed keywords

2,6 DIAMINO N [[1 (1 OXOTRIDECYL) 2 PIPERIDYL]METHYL]HEXANAMIDE; GLUTAMATE RECEPTOR; MORPHINE; NALOXONE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR;

ANIMAL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CELL; CELL MEMBRANE; CHEMISTRY; CINGULATE GYRUS; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFECT; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYMOLOGY; FOREBRAIN; GENE EXPRESSION; IMMUNOCYTOCHEMISTRY; MALE; MICROSCOPY; NONHUMAN; PHYSIOLOGY; PRIORITY JOURNAL; RAT; RAT STRAIN; STRIATE CORTEX; THALAMUS;

EID: 0347356264     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2003.09.019     Document Type: Article

References (72)

1. + current in mouse neocortical slices. J. Neurophysiol. 80:1998;1547-1551.
2. Barnes N.M., Sharp T. A review of central 5-HT receptors and their function. Neuropharmacology. 38:1999;1083-1152.
3. Bickel W.K., Higgins S.T., Stitzer M.L. Choice of blind methadone dose increases by methadone maintenance patients. Drug Alcohol Dep. 18:1986;165-171.
4. Bontempi B., Sharp F.R. Systemic morphine induced fos protein in the rat striatum and nucleus accumbens is regulated by mu opioid receptors in the substantia nigra and ventral tegmental area. J. Neurosci. 17:1997;8596-8612.
5. Bordi F., Ugolini A. Group I metabotropic glutamate receptors: implications for brain diseases. Prog. Neurobiol. 59:1999;55-79.
6. Bortolotto Z.A., Collinridge G.L. A role for protein kinase C in a form of metaplasticity that regulates the induction of long-term potentiation at CA1 synapses of the adult rat hippocampus. Eur. J. Neurosci. 12:2000;4055-4062.
7. Brandon N.J., Uren J.M., Kittler J.T., Wang H., Olsen R., Parker P.J., Moss S.J. Subunit-specific association of protein kinase C and the receptor for activated C kinase with GABA type A receptors. J. Neurosci. 19:1999;9228-9234.
8. Brown H.E., Garcia M.M., Harlan R.E. A two-focal-plane method for digital quantification of nuclear-stain immunocytochemistry data from large brain areas using NIH-Image software. Brain Res. Protocols. 2:1998;264-272.
9. Busquets X., Escriba P.V., Sastre M., Garcia-Sevilla J.A. Loss of protein kinase C-αβ in brain of heroin addicts and morphine-dependent rats. J. Neurochem. 64:1995;247-252.
10. Chang S.L., Squinto S.P., Harlan R.E. Morphine activation of c-Fos expression in rat brain. Biochem. Biophys. Res. Comm. 157:1988;698-704.
11. Chung H.J., Xia J., Scannevin R.H., Huganir R.L. Phosphorylation of the AMPA receptor subunit GluR2 differentially regulates its interaction with PDZ domain-containing proteins. J. Neurosci. 20:2000;7258-7267.
12. Colasanti B., Khazan N. Antagonism of the acute electroencephalic and behavioral effects of morphine in the rat by depletion of brain biogenic amines. Neuropharmacology. 12:1973;63-69.
13. Daw M.I., Chittajallu R., Bortolotto Z.A., Dev K.K., Duprat F., Henley J.M., Collingridge G.L., Isaac J.T. PDZ proteins interacting with C-terminal GluR2/3 are involved in a PKC-dependent regulation of AMPA receptors at hippocampal synapses. Neuron. 28:2000;873-886.
14. Dildy-Mayfield J.E., Harris R.A. Activation of protein kinase C inhibits kainate-induced currents in oocytes expressing glutamate receptor subunits. J. Neurochem. 62:1994;1639-1642.
15. D'Souza D.N., Harlan R.E., Garcia M.M. Sexual dimorphism in the response to N-methyl-D-aspartate receptor antagonists and morphine on behavior and c-Fos induction in the rat brain. Neuroscience. 93:1999;1539-1547.
16. D'Souza D.N., Harlan R.E., Garcia M.M. Sexually dimorphic responses to morphine and dizocilpine (MK-801): sex steroid-dependent and -independent mechanisms. J. Appl. Physiol. 92:2002;493-503.
17. Eidelberg E., Schwartz A.S. Possible mechanism of action of morphine on brain. Nature. 225:1970;1152-1153.
18. Escriba P.V., Garcia-Sevilla J.A. Parallel modulation of receptor for activated C kinase 1 and protein kinase C-α and β isoforms in brains of morphine-treated rats. Br. J. Pharmacol. 127:1999;343-348.
19. Frankel P.S., Harlan R.E., Garcia M.M. The 5-HT3 receptor antagonist, MDL 72222, dose-dependently potentiates morphine-induced immediate-early gene expression in the rat caudate-putamen. Brain Res. 814:1998;186-193.
20. Frankel P.S., Harlan R.E., Garcia M.M. Role of the dorsal raphe in morphine-induced IEG expression in the rat striatum. Brain Res. 842:1999;220-223.
21. 2+ release or protein kinase C activation significantly reduces the development of morphine dependence. Eur. J. Pharmacol. 300:1996;173-181.
22. Garcia M.M., Brown H.E., Harlan R.E. Alterations in immediate-early gene proteins in the rat forebrain induced by acute morphine injection. Brain Res. 692:1995;23-40.
23. Garcia M.M., Harlan R.E. Protein kinase C in central auditory pathways of the rat. J. Comp. Neurol. 385:1997;1-25.
24. Garcia M.M., Anderson A.T., Edwards R., Harlan R.E. Morphine induction of c-Fos expression in the rat forebrain through glutamatergic mechanisms: role of non-NMDA receptors. Neuroscience. 119:2003;787-794.
25. Granados-Soto V., Kalcheva I., Hua X., Newton A., Yaksh T.L. Spinal PKC activity and expression: role in tolerance produced by continuous spinal morphine infusion. Pain. 85:2000;395-404.
26. Harlan R.E., Garcia M.M. Drugs of abuse and immediate-early genes in the forebrain. Mol. Neurobiol. 16:1998;221-268.
27. Harlan R., Malcher-Lopes R., Cusick C., Garcia M.M. Morphine activates thalamo-striatal neurons in the rat. Drug Alcohol Depend. 63:2001;S63.
28. Harlan R.E., Webber D.S., Garcia M.M. Involvement of nitric oxide in morphine-induced c-Fos expression in the rat forebrain. Brain Res. Bull. 54:2001;207-212.
29. + channels in dendrites of hippocampal CA1 pyramidal neurons by activation of PKA and PKC. J. Neurosci. 18:1998;3521-3528.
30. Huang N.-K., Tseng C.-J., Wong C.-S., Tung C.-S. Effects of acute and chronic morphine on DOPAC and glutamate at subcortical DA terminals in awake rats. Pharm. Biochem. Behav. 56:1997;363-371.
31. Hughes P., Dragunow M. Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol. Rev. 47:1995;133-178.
32. Hyman S.E. Addiction to cocaine and amphetamine. Neuron. 16:1996;901-904.
33. Inoue M., Ueda H. Protein kinase C-mediated acute tolerance to peripheral mu opioid analgesia in the bradykinin-nociception test in mice. J. Pharmacol. Exp. Ther. 293:2000;662-669.
34. Kramer H.K., Poblete J.C., Azmitia E.C. Activation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA) occurs through the stimulation of serotonin receptors and transporter. Neuropsychopharmacology. 17:1997;117-129.
35. Kramer H.K., Poblete J.C., Azmitia E.C. Characterization of the translocation of protein kinase C (PKC) by 3,4-methylenedioxymethamphetamine (MDMA/ecstasy) in synaptosomes: evidence for a presynaptic localization involving the serotonin transporter (SERT). Neuropsychopharmacology. 19:1998;265-277.
36. Kramer H.K., Simon E.J. Role of protein kinase C (PKC) in agonist-induced mu-opioid receptor down-regulation: I. PKC translocation to the membrane of SH-SY5Y neuroblastoma cells is induced by mu-opioid agonists. J. Neurochem. 72:1999;585-593.
37. Lamb R.J., Preston K.L., Schindler C.W., Meisch R.A., Davis F., Katz J.L., Henningfield J.E., Goldberg S.R. The reinforcing and subjective effects of morphine in post-addicts: a dose-response study. J. Pharm. Exp. Ther. 259:1991;1165-1173.
38. Leonard A.S., Hell J.W. Cyclic AMP-dependent protein kinase and protein kinase C phosphorylate N-methyl-D-aspartate receptors at different sites. J. Biol. Chem. 272:1997;12107-12115.
39. Li Y., Roerig S.C. Alteration of spinal protein kinase C expression and kinetics in morphine, but not clonidine, tolerance. Biochem. Pharmacol. 58:1999;493-501.
40. 1 and N-methyl-D-aspartate receptors. Proc. Natl. Acad. Sci. USA. 91:1994;8537-8541.
41. MacDonald J.F., Kotecha S.A., Lu W.Y., Jackson M.F. Convergence of PKC-dependent kinase signal cascades on NMDA receptors. Curr. Drug Targets. 2:2001;299-312.
42. Mansour A., Fox C.A., Burke S., Meng F., Thompson R.C., Akil H., Watson S.J. Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: an in situ hybridization study. J. Comp. Neurol. 350:1994;412-438.
43. Mayer D.J., Mao J., Price D.D. The development of morphine tolerance and dependence is associated with translocation of protein kinase C. Pain. 61:1995;365-374.
44. Mestek A., Hurley J.H., Bye L.S., Campbell A.D., Chen Y., Tian M., Liu J., Schulman H., Yu L. The human μ opioid receptor: modulation of functional desensitization by calcium/calmodulin-dependent protein kinase and protein kinase C. J. Neurosci. 15:1995;2396-2406.
45. Mochly-Rosen D., Khaner H., Lopez J. Identification of intracellular receptor proteins for activated protein kinase C. Proc. Natl. Acad. Sci. USA. 88:1991;3997-4000.
46. Molina V.A., Heyser C.J., Spear L.P. Chronic variable stress enhances the stimulatory action of a low dose of morphine: reversal by desipramine. Eur. J. Pharm. 260:1994;57-64.
47. Moratalla R., Elibol B., Vallejo M., Graybiel A.M. Network-level changes in expression of inducible Fos-Jun proteins in the striatum during chronic cocaine treatment and withdrawal. Neuron. 17:1996;147-156.
48. Moss S.J., Smart T.G. Modulation of amino acid-gated ion channels by protein phosphorylation. Int. Rev. Neurobiol. 39:1996;1-52.
49. Narita M., Makimura M., Feng Y., Hoskins B., Ho I.K. Influence of chronic morphine treatment on protein kinase C activity: comparison with butorphanol and implication for opioid tolerance. Brain Res. 650:1994;175-179.
50. Narita M., Ohsawa M., Mizoguchi H., Kamei J., Tseng L.F. Pretreatment with protein kinase C activator phorbol 12,13-dibutyrate attenuates the antinociception induced by mu- but not epsilon-opioid receptor agonist in the mouse. Neuroscience. 76:1997;291-298.
51. Narita M., Aoki T., Ozaki S., Yajima Y., Suzuki T. Involvement of protein kinase Cgamma isoform in morphine-induced reinforcing effects. Neuroscience. 103:2001;309-314.
52. Narita M., Mizuo K., Shibasaki M., Narita M., Suzuki T. Up-regulation of the G(q/11alpha) protein and protein kinase C during the development of sensitization to morphine-induced hyperlocomotion. Neuroscience. 111:2002;127-132.
53. Ohsawa M., Kamei J. Possible involvement of protein kinase C in the attenuation of the morphine-induced Straub tail in diabetic mice. Eur. J. Pharmacol. 362:1998;47-51.
54. G. Paxinos, C. Watson (Eds.), The Rat Brain in Sterotaxic Coordinates, 4th edition, Academic Press, NewYork, 1998 [electronic version].
55. Pisani A., Calabresi P., Centonze D., Bernardi G. Enhancement of NMDA responses by group I metabotropic glutamate receptor activation in striatal neurons. Br. J. Pharmacol. 120:1997;1007-1014.
56. Self D.W., Nestler E.J. Molecular mechanisms of drug reinforcement and addiction. Annu. Rev. Neurosci. 18:1995;463-495.
57. Smith F.L., Lohmann A.B., Dewey W.L. Involvement of phospholipid signal transduction pathways in morphine tolerance in mice. Br. J. Pharmacol. 128:1999;220-226.
58. Spampinato U., Esposito E., Romandini S., Samanin R. Changes in serotonin and dopamine metabolism in various forebrain areas of rats injected with morphine either systemically or in the raphe nuclei dorsalis and medianus. Brain Res. 328:1985;89-95.
59. Steketee J.D., Rowe L.A., Chandler L.J. The effects of acute and repeated cocaine injections on protein kinase C activity and isoform levels in dopaminergic brain regions. Neuropharmacology. 37:1998;339-347.
60. Tanaka C., Nishizuka Y. The protein kinase C family for neuronal signaling. Annu. Rev. Neurosci. 17:1994;551-567.
61. Tanaka C., Siato N. Localization of subspecies of protein kinase C in the mammalian central nervous system. Neurochem. Int. 21:1992;499-512.
62. Tao R., Auerbach S.B. Increased extracellular serotonin in rat brain after systemic or intraraphe administration of morphine. J. Neurochem. 63:1994;517-524.
63. Tokuyama S., Feng Y., Wakabayashi H., Ho I.K. Possible involvement of protein kinases in physical dependence on opioids: studies using protein kinase inhibitors, H-7 and H-8. Eur. J. Pharm. 284:1995;101-107.
64. Ueda H., Inoue M., Matsumoto T. Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia. J. Neurosci. 21:2001;2967-2973.
65. Uphouse L. Multiple serotonin receptors: too many, not enough, or just the right number? Neurosci. Biobehav. Rev. 21:1997;679-698.
66. Vaughan P.F., Walker J.H., Peers C. The regulation of neurotransmitter secretion by protein kinase C. Mol. Neurobiol. 18:1998;125-155.
67. Ventayol P., Busquets X., Garcia-Sevilla J.A. Modulation of immunoreactive protein kinase C-alpha and beta isoforms and G proteins by acute and chronic treatments with morphine and other opiate drugs in rat brain. Naunyn-Schmiedebergs Arch. Pharmacol. 355:1997;491-500.
68. Wang L.Y., Dudek E.M., Browning M.D., MacDonald J.F. Modulation of AMPA/kainate receptors in cultured murine hippocampal neurones by protein kinase C. J. Physiol. 475:1994;431-437.
69. Xia J., Zhang X., Staudinger J., Huganir R.L. Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. Neuron. 22:1999;179-187.
70. Xiong Z.G., Raouf R., Lu W.Y., Wang L.Y., Orser B.A., Dudek E.M., Browning M.D., MacDonald J.F. Regulation of N-methyl-D-aspartate receptor function by constitutively active protein kinase C. Mol. Pharmacol. 54:1998;1055-1063.
71. Yoshihara C., Saito N., Taniyama K., Tanaka C. Differential localization of four subspecies of protein kinase C in the rat striatum and substantia nigra. J. Neurosci. 11:1991;690-700.
72. Zhang L., Yu Y., Mackin S., Weight F.F., Uhl G.R., Wang J.B. Differential mu opiate receptor phosphorylation and desensitization induced by agonists and phorbol esters. J. Biol. Chem. 271:1996;11449-11454.